A phase 1b study of onvansertib, a novel oral PLK1 inhibitor, in combination therapy for patients with relapsed or refractory acute myeloid leukemia
| Image |  |
|---|---|
| Description | scientific article published on 30 September 2020 |
| Author/s |
author: Amer M Zeidan Errin Samuëlsz Pamela S Becker Tara L Lin |
| Publication date | September 30, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |